<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37803288</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>09</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2369</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>06</Day></PubDate></JournalIssue><Title>BMC nephrology</Title><ISOAbbreviation>BMC Nephrol</ISOAbbreviation></Journal><ArticleTitle>Proliferative glomerulonephritis with monoclonal IgG Lambda deposits caused by plasmablastic lymphoma: a case report.</ArticleTitle><Pagination><StartPage>297</StartPage><MedlinePgn>297</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">297</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12882-023-03351-7</ELocationID><Abstract><AbstractText Label="INTRODUCTION">As a very rare form of B-cell lymphoma, plasmablastic lymphoma (PBL) typically occurs in patients with underlying immunosuppression, including human immunodeficiency virus (HIV), organ transplantation, and autoimmune diseases. For HIV-positive patients, PBL normally originates in the gastrointestinal tract, especially from the oral cavity in most cases. It is extremely rare to find abdominal cavity involvement in PBL, and there has been no previously reported instance of proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID) attributed to monoclonal IgG (MIgG) lambda secreted by PBL.</AbstractText><AbstractText Label="CASE PRESENTATION">We report the case of an HIV-negative female with nephrotic syndrome, renal insufficiency, and multiple swollen lymph nodes. Ascitic fluid cytology revealed a high level of plasmablast-like lymphocytes with the restriction of lambda light chains. Besides, the renal biopsy revealed PGNMID, which could presumably be secondary to MIgG-lambda-secreting by PBL. MIgG-lambda-restricted expression was discovered earlier in the kidney tissue than in the blood.</AbstractText><AbstractText Label="CONCLUSION">The diagnostic landscape for PBL is notoriously intricate, necessitating a multifaceted and nuanced approach to mitigate the risks of erroneous identification.</AbstractText><CopyrightInformation>&#xa9; 2023. BioMed Central Ltd., part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Ling-Yan</ForeName><Initials>LY</Initials><AffiliationInfo><Affiliation>Department of Nephrology, The First Affiliated Hospital of Huzhou Teachers College, the First People's Hospital of Huzhou, Huzhou, 313000, Zhejiang, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Nephrology, The First Affiliated Hospital of Huzhou Teachers College, the First People's Hospital of Huzhou, Huzhou, 313000, Zhejiang, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiu</LastName><ForeName>Feng-Ping</ForeName><Initials>FP</Initials><AffiliationInfo><Affiliation>Department of Nephrology, The First Affiliated Hospital of Huzhou Teachers College, the First People's Hospital of Huzhou, Huzhou, 313000, Zhejiang, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Zhen-Yu</ForeName><Initials>ZY</Initials><AffiliationInfo><Affiliation>Department of Nephrology, The First Affiliated Hospital of Huzhou Teachers College, the First People's Hospital of Huzhou, Huzhou, 313000, Zhejiang, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiao-Yi</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>Department of Nephrology, The First Affiliated Hospital of Huzhou Teachers College, the First People's Hospital of Huzhou, Huzhou, 313000, Zhejiang, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiao-Lan</ForeName><Initials>XL</Initials><AffiliationInfo><Affiliation>Department of Pathology, The First Affiliated Hospital of Huzhou Teachers College, the First People's Hospital of Huzhou, Huzhou, 313000, Zhejiang, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Zhan-Qin</ForeName><Initials>ZQ</Initials><AffiliationInfo><Affiliation>Department of Nephrology, The First Affiliated Hospital of Huzhou Teachers College, the First People's Hospital of Huzhou, Huzhou, 313000, Zhejiang, P.R. China. szqxx2007@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Nephrol</MedlineTA><NlmUniqueID>100967793</NlmUniqueID><ISSNLinking>1471-2369</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069293" MajorTopicYN="Y">Plasmablastic Lymphoma</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005921" MajorTopicYN="Y">Glomerulonephritis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="Y">HIV Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015432" MajorTopicYN="Y">Glomerulonephritis, Membranoproliferative</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Plasmablastic lymphoma</Keyword><Keyword MajorTopicYN="N">Proliferative glomerulonephritis with monoclonal IgG lambda deposits</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>9</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>7</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>6</Day><Hour>23</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37803288</ArticleId><ArticleId IdType="pmc">PMC10559464</ArticleId><ArticleId IdType="doi">10.1186/s12882-023-03351-7</ArticleId><ArticleId IdType="pii">10.1186/s12882-023-03351-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):1&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pubmed">11904577</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansra D, Montague N, Stefanovic A, Akunyili I, Harzand A, Natkunam Y, et al. Oral and extraoral plasmablastic lymphoma: similarities and differences in clinicopathologic characteristics. Am J Clin Pathol. 2010;134(5):710&#x2013;9. doi: 10.1309/ajcpjh6keusecqlu.</Citation><ArticleIdList><ArticleId IdType="doi">10.1309/ajcpjh6keusecqlu</ArticleId><ArticleId IdType="pubmed">20959653</ArticleId></ArticleIdList></Reference><Reference><Citation>Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375&#x2013;90. doi: 10.1182/blood-2016-01-643569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2016-01-643569</ArticleId><ArticleId IdType="pmc">PMC4874220</ArticleId><ArticleId IdType="pubmed">26980727</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapkota S, Priyadarshini M, Hazarika D, Swamy S, Naik R. Plasmablastic lymphoma involving kidney in an HIV positive patient: a Case Report with Review of the literature. Indian J Nephrol. 2021;31(2):176&#x2013;8. doi: 10.4103/ijn.IJN_277_18.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijn.IJN_277_18</ArticleId><ArticleId IdType="pmc">PMC8240923</ArticleId><ArticleId IdType="pubmed">34267442</ArticleId></ArticleIdList></Reference><Reference><Citation>Borenstein J, Pezzella F, Gatter KC. Plasmablastic lymphomas may occur as post-transplant lymphoproliferative disorders. Histopathology. 2007;51(6):774&#x2013;7. doi: 10.1111/j.1365-2559.2007.02870.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2559.2007.02870.x</ArticleId><ArticleId IdType="pubmed">17944927</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbas SH, Goyal G, Noory MA, Loo A. Plasmablastic lymphoma found on autopsy in a post-transplant patient. Cureus. 2020;12(5):e8109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7292721</ArticleId><ArticleId IdType="pubmed">32542162</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramadas P, Williams M, Duggan DB. Plasmablastic lymphoma or Plasmablastic Myeloma: a case of post-transplant lymphoproliferative disorder. Case Rep Hematol. 2021;2021:4354941.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8490046</ArticleId><ArticleId IdType="pubmed">34616575</ArticleId></ArticleIdList></Reference><Reference><Citation>Nwanwene K, Khan NAJ, Alsharedi M. Testicular plasmablastic lymphoma in an HIV-Negative patient: a rare case presentation. J Investig Med High Impact Case Rep. 2021;9:23247096211017423. doi: 10.1177/23247096211017423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/23247096211017423</ArticleId><ArticleId IdType="pmc">PMC8155771</ArticleId><ArticleId IdType="pubmed">34032157</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi Y, Saiga I, Fukushima J, Seki N, Sugimoto N, Hori A, et al. Plasmablastic lymphoma of the retroperitoneum in an HIV-negative patient. Pathol Int. 2009;59(12):868&#x2013;73. doi: 10.1111/j.1440-1827.2009.02457.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1827.2009.02457.x</ArticleId><ArticleId IdType="pubmed">20021612</ArticleId></ArticleIdList></Reference><Reference><Citation>Mwazha A, Nhlonzi GB, Mazengenya P. Gastrointestinal Tract Plasmablastic Lymphoma in HIV-Infected adults: a histopathological review. Int J Surg Pathol. 2020;28(7):735&#x2013;48. doi: 10.1177/1066896920932272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1066896920932272</ArticleId><ArticleId IdType="pubmed">32552168</ArticleId></ArticleIdList></Reference><Reference><Citation>Tille JC, Pelte MF, Schwartz J, Dietrich PY, McKee TA. Plasmablastic lymphoma clinically presenting in the urinary tract. Ann Diagn Pathol. 2012;16(3):219&#x2013;23. doi: 10.1016/j.anndiagpath.2011.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anndiagpath.2011.02.002</ArticleId><ArticleId IdType="pubmed">21531157</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafarizade M, Goli K, D&#x2019;Agati V, Dulaimi E, Daniel K, Lash B, et al. Light chain cast nephropathy caused by plasmablastic lymphoma of the bladder. Clin Nephrol Case Stud. 2021;9:72&#x2013;80. doi: 10.5414/CNCS110339.</Citation><ArticleIdList><ArticleId IdType="doi">10.5414/CNCS110339</ArticleId><ArticleId IdType="pmc">PMC8259465</ArticleId><ArticleId IdType="pubmed">34235044</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbock GS, Morrisseau PM, Vinson RK. Acute obstructive renal failure secondary to granulocytic sarcoma (chloroma). Urology.1986;27(3):268 &#x2013; 70. 10.1016/0090-4295(86)90288-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">3082059</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasr SH, Alobeid B, Jacobs JM, Peacock TE, D&#x2019;Agati VD, Markowitz GS. Methotrexate-associated B-cell lymphoma presenting with acute renal failure and bilateral nephromegaly. Kidney Int. 2007;71(3):272&#x2013;5. doi: 10.1038/sj.ki.5001942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ki.5001942</ArticleId><ArticleId IdType="pubmed">17035943</ArticleId></ArticleIdList></Reference><Reference><Citation>Audard V, Larousserie F, Grimbert P, Abtahi M, Sotto JJ, Delmer A, et al. Minimal change nephrotic syndrome and classical Hodgkin&#x2019;s lymphoma: report of 21 cases and review of the literature. Kidney Int. 2006;69(12):2251&#x2013;60. doi: 10.1038/sj.ki.5000341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ki.5000341</ArticleId><ArticleId IdType="pubmed">16672913</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen LJ, Rennke HG, Laubach JP, Humphreys BD. The spectrum of kidney involvement in lymphoma: a case report and review of the literature. Am J Kidney Dis. 2010;56(6):1191&#x2013;6. doi: 10.1053/j.ajkd.2010.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2010.07.009</ArticleId><ArticleId IdType="pmc">PMC3222147</ArticleId><ArticleId IdType="pubmed">20843590</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda K, Ohno H, Hane M, Yokoi H, Okada M, Honma T, et al. Development of a sensitive two-site immunoradiometric assay for parathyroid hormone-related peptide: evidence for elevated levels in plasma from patients with adult T-cell leukemia/lymphoma and B-cell lymphoma. J Clin Endocrinol Metab. 1994;79(5):1322&#x2013;7. doi: 10.1210/jcem.79.5.7962324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jcem.79.5.7962324</ArticleId><ArticleId IdType="pubmed">7962324</ArticleId></ArticleIdList></Reference><Reference><Citation>Audard V, Georges B, Vanhille P, Toly C, Deroure B, Fakhouri F, et al. Renal lesions associated with IgM-secreting monoclonal proliferations: revisiting the disease spectrum. Clin J Am Soc Nephrol. 2008;3(5):1339&#x2013;49. doi: 10.2215/CJN.01600408.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.01600408</ArticleId><ArticleId IdType="pmc">PMC2518806</ArticleId><ArticleId IdType="pubmed">18632851</ArticleId></ArticleIdList></Reference><Reference><Citation>Veroux P, Veroux M, Nicosia A, Bonanno MG, Tumminelli MG, Milone P, et al. Thrombectomy of the inferior vena cava from recurrent low-grade endometrial stromal sarcoma: case report and review of the literature. J Surg Oncol. 2000;74(1):45&#x2013;8. doi: 10.1002/1096-9098(200005)74:1&lt;45::aid-jso11&gt;3.0.co;2-k.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1096-9098(200005)74:1&lt;45::aid-jso11&gt;3.0.co;2-k</ArticleId><ArticleId IdType="pubmed">10861609</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronco P, Plaisier E, Mougenot B, Aucouturier P. Immunoglobulin light (heavy)-chain deposition disease: from molecular medicine to pathophysiology-driven therapy. Clin J Am Soc Nephrol.2006;1(6):1342-50. https://doi.org/.</Citation><ArticleIdList><ArticleId IdType="pubmed">17699367</ArticleId></ArticleIdList></Reference><Reference><Citation>Da&#x2019;as N, Polliack A, Cohen Y, Amir G, Darmon D, Kleinman Y, et al. Kidney involvement and renal manifestations in non-hodgkin&#x2019;s lymphoma and lymphocytic leukemia: a retrospective study in 700 patients. Eur J Haematol. 2001;67(3):158&#x2013;64. doi: 10.1034/j.1600-0609.2001.5790493.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-0609.2001.5790493.x</ArticleId><ArticleId IdType="pubmed">11737248</ArticleId></ArticleIdList></Reference><Reference><Citation>Milani P, Merlini G, Palladini G. Light Chain Amyloidosis[J]. Mediterr J Hematol Infect Dis.2018;10(1):e2018022. https://doi.org10.4084/mjhid.2018.022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5841939</ArticleId><ArticleId IdType="pubmed">29531659</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X, Duan M, Hu L, Zhou D, Zhang W. Plasmablastic lymphoma: review of 60 chinese cases and prognosis analysis. Med (Baltim) 2017;96(9):e5981. doi: 10.1097/md.0000000000005981.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/md.0000000000005981</ArticleId><ArticleId IdType="pmc">PMC5340428</ArticleId><ArticleId IdType="pubmed">28248855</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M, Liu B, Liu B, Wang Q, Ding L, Xia C, et al. Human immunodeficiency virus-negative plasmablastic lymphoma: a comprehensive analysis of 114 cases. Oncol Rep. 2015;33(4):1615&#x2013;20. doi: 10.3892/or.2015.3808.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/or.2015.3808</ArticleId><ArticleId IdType="pmc">PMC4358079</ArticleId><ArticleId IdType="pubmed">25695332</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukswai N, Lyapichev K, Khoury JD, Medeiros LJ. Diffuse large B-cell lymphoma variants: an update. Pathology. 2020;52(1):53&#x2013;67. doi: 10.1016/j.pathol.2019.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pathol.2019.08.013</ArticleId><ArticleId IdType="pubmed">31735345</ArticleId></ArticleIdList></Reference><Reference><Citation>Boy SC, van Heerden MB, Raubenheimer EJ, van Heerden WF. Plasmablastic lymphomas with light chain restriction - plasmablastic extramedullary plasmacytomas? J Oral Pathol Med. 2010;39(5):435&#x2013;9. doi: 10.1111/j.1600-0714.2009.00874.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0714.2009.00874.x</ArticleId><ArticleId IdType="pubmed">20537055</ArticleId></ArticleIdList></Reference><Reference><Citation>Li SJ, Chen HP, Chen YH, Zhang L, Tu YM, Liu Z. Renal involvement in Non-Hodgkin Lymphoma: proven by renal biopsy. PLoS ONE. 2014;9(4):e95190. doi: 10.1371/journal.pone.0095190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0095190</ArticleId><ArticleId IdType="pmc">PMC3986362</ArticleId><ArticleId IdType="pubmed">24733356</ArticleId></ArticleIdList></Reference><Reference><Citation>Sethi S, Rajkumar SV, D&#x2019;Agati VD. The complexity and heterogeneity of Monoclonal Immunoglobulin-Associated Renal Diseases. J Am Soc Nephrol. 2018;29(7):1810&#x2013;23. doi: 10.1681/asn.2017121319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/asn.2017121319</ArticleId><ArticleId IdType="pmc">PMC6050917</ArticleId><ArticleId IdType="pubmed">29703839</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowalewska J, Nicosia RF, Smith KD, Kats A, Aplers CE. Patterns of glomerular injury in kidneys infiltrated by lymphoplasmacytic neoplasms. Hum Pathol. 2011;42(6):896&#x2013;903. doi: 10.1016/j.humpath.2010.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humpath.2010.09.009</ArticleId><ArticleId IdType="pubmed">21288559</ArticleId></ArticleIdList></Reference><Reference><Citation>Sethi S, Zand L, Leung N, Smith RJ, Jevremonic D, Herrmann SS, et al. Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy. Clin J Am Soc Nephrol. 2010;5(5):770&#x2013;82. doi: 10.2215/cjn.06760909.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/cjn.06760909</ArticleId><ArticleId IdType="pmc">PMC2863981</ArticleId><ArticleId IdType="pubmed">20185597</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasr SH, Larsen CP, Sirac C, Theis JD, Domenger C, Chauvet S, et al. Light chain only variant of proliferative glomerulonephritis with monoclonal immunoglobulin deposits is associated with a high detection rate of the pathogenic plasma cell clone. Kidney Int. 2020;97(3):589&#x2013;601. doi: 10.1016/j.kint.2019.10.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2019.10.025</ArticleId><ArticleId IdType="pubmed">32001067</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung N, Bridoux F, Batuman V, Chaidos A, Cockwell P, D&#x2019;Agati VD, et al. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the international kidney and monoclonal Gammopathy Research Group. Nat Rev Nephrol. 2019;15(1):45&#x2013;59. doi: 10.1038/s41581-018-0077-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-018-0077-4</ArticleId><ArticleId IdType="pmc">PMC7136169</ArticleId><ArticleId IdType="pubmed">30510265</ArticleId></ArticleIdList></Reference><Reference><Citation>Andeen NK, Abdulameer S, Charu V, Zuckerman JE, Troxell M, Kambham N, et al. A diverse spectrum of Immune Complex- and complement-mediated kidney Diseases is Associated with Mantle Cell Lymphoma. Kidney Int Rep. 2022;7(3):568&#x2013;79. doi: 10.1016/j.ekir.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ekir.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8897291</ArticleId><ArticleId IdType="pubmed">35257069</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogan JJ, Alexander MP, Leung N. Dysproteinemia and the kidney: core curriculum 2019. Am J Kidney Dis. 2019;74(6):822&#x2013;36. doi: 10.1053/j.ajkd.2019.04.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2019.04.029</ArticleId><ArticleId IdType="pubmed">31331759</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo JJ, Winer ES, Stachurski D, Perez K, Jabbour M, Milani C, et al. Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma. Leuk Lymphoma. 2010;51(11):2047&#x2013;53. doi: 10.3109/10428194.2010.516040.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10428194.2010.516040</ArticleId><ArticleId IdType="pubmed">20919850</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan M, Dong Z, Zhao F, Chauncey T, Deauna-Limayo D, Wang-Rodriguez J, et al. CD20-positive plasmablastic lymphoma with excellent response to bortezomib combined with rituximab. Eur J Haematol. 2014;93(1):77&#x2013;80. doi: 10.1111/ejh.12286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejh.12286</ArticleId><ArticleId IdType="pubmed">24528507</ArticleId></ArticleIdList></Reference><Reference><Citation>Rong C, Sheng L, Wu A, Sun Y, Ouyang G. Allogeneic hematopoietic stem cell transplantation in a patient with HIV-negative recurrent plasmablastic lymphoma: a case report. Med (Baltim) 2021;100(7):e24498. doi: 10.1097/MD.0000000000024498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000024498</ArticleId><ArticleId IdType="pmc">PMC7899902</ArticleId><ArticleId IdType="pubmed">33607779</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>